From the president: Medicine safety is vital to improving disability care
Last month, I had the pleasure of meeting many of you at our annual PSA22 flagship conference in Sydney, where we also launched our...
The King Review – where to now?
As PSA National President, I will continue to work with the government and other stakeholders to unlock opportunities for pharmacists to realise their full...
Help patients beat the extreme heat
Australia is in the midst of a record-breaking heatwave – with Western Australia, South Australia, Tasmania, Victoria, the ACT and NSW all reaching maximum...
Pregabalin add-on for drug-resistant focal epilepsy
This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1
Introduction
Approximately 3–3.5% of Australians will experience epilepsy at some point...
Pharmacists’ true value not yet realised: PSA
Pharmacists are the healthcare professionals best placed to address the crisis in medicine safety in Australia, and could contribute to cost savings of $1.4...
Opioids, antidepressants and the risk of hip fracture
A recent study identified that the risk of hip fracture was increased with the use of psychotropic drugs in elderly people. The highest risk...
